Comparative Effects of Anti-Platelet Agents as Adjuncts to Tissue Plasminogen Activator in a Dog Model of Occlusive Coronary Thrombosis

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1994.tb13063.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Thrombolytic Effects of a Novel Modified Tissue Plasminogen Activator, E6010, on Coronary Thrombosis in the Pig.

The Japanese Journal of Pharmacology
1992English

Recombinant Tissue Plasminogen Activator (rtPA) for the Treatment of Hepatic Veno-Occlusive Disease (VOD)

Bone Marrow Transplantation
TransplantationHematology
1999English

Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced in Vitro Cerebral Angiogenesis

PLoS ONE
Multidisciplinary
2012English

Genome Response to Tissue Plasminogen Activator in Experimental Ischemic Stroke

BMC Genomics
BiotechnologyGenetics
2010English

Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator

Surgery for Cerebral Stroke
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy